She Blinded Me With Science: What We’re Reading, May 2017

Each month, GMO Answers compiles a few stories we think particularly noteworthy. Science is everywhere, and that was especially true in the stories that caught our eye this past April. So go with the flow, lose control, feel the power, fight your resistance, be a catalyst, start a reaction, keep an ion the ball, and join us in finding out the latest in the world of science and GMOs in this month’s What We’re Reading post:

To learn more about the science of GMOs, agriculture, and plants, please visit the GMO Answers website.

Filed under: Farmer Gene, Food And Agriculture, , , , , , , , , , ,

Convention Programming to Feature “One Health” Concept

Bio-based Technologies Address Human, Animal, Plant and Environmental Health

At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all interconnected. At BIO’s 2017 International Convention (June 19-22 in San Diego), programming will feature the One Health concept through stories that show how science and technology are making tomorrow’s breakthroughs possible.

On Monday, June 19, BIO will host “One Health Day,” bringing together different parts of the BIO family with sessions focused on issues linking human, animal and environmental health. Scheduled speakers include:

Keynote:  One Health for the 21st Century

  • Dr. William Karesh, Executive Vice President for Health and Policy at EcoHealth Alliance

“The very concept of ‘One Health’ is ancient,” says Dr. William Karesh, Executive Vice President for Health and Policy at EcoHealth Alliance. “But our world has changed dramatically, and what’s really exciting is that with 21st Century innovation we have the opportunity to begin to end the pandemic era.”

Human, Animal and Plant Health Connectedness – Industry’s Role:

  • Dr. Carsten Brunn, Bayer’s Head of Pharmaceuticals, Americas Region
  • Frank Terhorst, Bayer’s Global Head of Seeds

“With emerging issues like a rapidly aging population and new and increasingly complex medical needs, our industry is at the forefront of advancements in science and technology that will help cure and prevent some of the most difficult-to-treat conditions, and improve lives,” said Dr. Carsten Brunn, Bayer’s Head of Pharmaceuticals, Americas Region. “With Bayer’s focus across the life science ecosystem, we are actively working to discover and develop innovations that impact the health of people, animals, and plants.”

“As the world’s population is projected to increase by more than three billion people in the next thirty years, we will require an adequate supply of healthy food as well as improved medical care,” stated Frank Terhorst, global head of seeds at Bayer CropScience. “Our research and development activities, fundamental to the well-being of society, are therefore linked by the concept of ‘One Health,’ with the goal of finding solutions to some of the major challenges of our time.”

Panel Discussion:  How to Move “One Health” Forward

  • Dr. Eddie Sullivan, CEO, SAB Biotherapeutics and Chairman, BIO Food & Ag Section Governing Board (moderator)
  • Dr. Laura Kahn, Research Scholar, Woodrow Wilson School of Public and International Affairs, Princeton University and Co-Founder, One Health Initiative
  • Dr. Nikos Gurfield, Adjunct Professor of Pathology, UC San Diego and County Veterinarian, San Diego County Vector Disease and Diagnostic Laboratory
  • Dr. William Karesh, Executive Vice President for Health and Policy at EcoHealth Alliance

“Science and technology hold the promise of securing a healthier world for humans, animals and the environment,” says Dr. Eddie Sullivan, CEO, SAB Biotherapeutics and Chairman, BIO Food & Ag Section Governing Board. “To make these breakthroughs a reality, we’ll need a collaborative approach for addressing existing political and economic obstacles and opportunities.”

In our speaker presentations and panel discussions, attendees will hear stories that illustrate the concept of “One Health” and how modern technologies are enabling us to solve global challenges through a collaborative One Health-focused approach. Panelists will also explore the barriers to success and what industry and others can do to solve the problems One Health is poised to address.

BIO 2017 International Convention (BIO 2017) is in San Diego June 19-22 and registration is now open! Check out the complete BIO 2017 program including Keynotes, Super Sessions, Educational Tracks and Fireside Chats with scientific experts, government leaders and leading biotech CEOs. And stay tuned for more updates as we approach BIO 2017!

Filed under: Food And Agriculture, , , , , , , , , , , ,

#BeBoldForChange: BIO Rosalind Franklin Award and Intl. Women’s Day!

International Women’s Day (IWD) is celebrated each year on March 8. It is a global day celebrating the social, economic, cultural and political achievements of women. IWD has been observed since the early 1900’s and is a collective day of global celebration and a call for gender parity. No one government, NGO, charity, corporation, academic institution, women’s network or media hub is solely responsible for International Women’s Day. Many organizations declare an annual IWD theme that supports their specific agenda or cause.

To celebrate IWD, BIO saw it fitting to announce that it is now accepting nominations for its annual Rosalind Franklin Award. Rosalind Franklin conceived and captured Photograph 51 of the “B” form of DNA in 1952, while at King’s College in London. This photograph, acquired through 100 hours of X-ray exposure from a machine Dr. Franklin herself refined, revealed the structure of DNA. The discovery of the structure of DNA was the single most important advance of modern biology. James Watson and Francis Crick, working at Cambridge University, used Photograph 51 as the basis for their famous model of DNA, which earned them a Nobel Prize in 1962. Though sometimes overlooked, Rosalind Franklin’s critical work and discovery in the field has allowed the biotechnology industry to become what it is today.

Brent Erickson, Executive Vice President, Industrial and Environmental at BIO, stated, “Rosalind Franklin is an inspiration to female scientists; and yet the importance of her involvement in the discovery of DNA is often undervalued. With this award we hope to honor Rosalind Franklin’s legacy and all women who have who have defied odds and made lasting contributions to the field of biotechnology.”

Nominees must be living individuals who exhibit leadership qualities, and have pioneered efforts in industrial biotechnology. Applicants should demonstrate significant innovative contributions in a field integral to the advancement of a biobased economy.

The Award will again be sponsored by the Rosalind Franklin Society whose goal is to support and showcase the careers of eminent women in science.

The 2017 BIO Rosalind Franklin Award will be presented at the 2017 World Congress on Industrial Biotechnology, which will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal, Québec, Canada. The deadline for nominations is March 24, 2017.

For more information on the conference please visit www.bio.org/worldcongress.  For assistance, please contact worldcongress@bio.org.

To learn more about International Women’s Day and this year’s theme #BeBoldForChange, follow @womensday.